< Back to previous page
Researcher
Bénédicte Dubois
- Disciplines:Neurosciences
Affiliations
- Research Group Experimental Neurology (Division)
Responsible
From1 Feb 2014 → Today - Laboratory for Neuroimmunology (Lab)
Responsible
From1 Jan 2006 → Today - Laboratory for Neuroimmunology (Lab)
Member
From1 Jan 2012 → 31 Mar 2016 - Research Group Experimental Neurology (Division)
Member
From1 Oct 2003 → Today - Department of Neurosciences (Department)
Member
From1 Oct 2001 → 30 Sep 2003 - Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 19
- Multiple sclerosis immunogenetics: moving to multimodal single-cell resolutionFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- The role of natural killer cell subsets in the multiple sclerosis brainFrom1 Jan 2024 → TodayFunding: Private funding of national origin - undefined
- Multiple sclerosis immunogenetics.From1 Oct 2023 → 31 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying novel insights into molecular pathways that contribute to axonal loss in progressive multiple sclerosis.From1 Oct 2022 → TodayFunding: BOF - ZAP BOF mandates
- Elucidating the role of Epstein-Barr virus in multiple sclerosis pathophysiology.From1 Oct 2022 → TodayFunding: FWO fellowships
- The Role of Natural Killer Cells in Multiple SclerosisFrom1 Sep 2021 → TodayFunding: FWO fellowships
- Multiple sclerosis immunogenetics: moving to multi-omics single-cell resolutionFrom1 Sep 2021 → TodayFunding: FWO fellowships, Foreign private sponsor - undefined
- Inter-individual variation in susceptibility to and disease course of multiple sclerosisFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Somatic mutations leading to CD8+ T cell proliferation contribute to the pathogenesis of multiple sclerosisFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Multiple sclerosis postdoctoral research fellowship Emanuela Oldoni.From5 Feb 2018 → 4 Feb 2020Funding: Foreign Nonprofit organisations and equivalents
Publications
11 - 20 of 100
- Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020)(2022)
Authors: Paul De Munter, Bénédicte Dubois, Rene Westhovens
- Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies(2022)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
Pages: 4565 - 4574 - Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study(2022)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
- From susceptibility to heterogeneity in multiple sclerosis: insights from genetic epidemiology(2022)
Authors: Marijne Vandebergh, An Goris, Bénédicte Dubois
- Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study(2022)
Authors: Marijne Vandebergh, Sara Becelaere, Bénédicte Dubois, An Goris
- Somatic mosaicism in multiple sclerosis: Detection and insights into disease(2022)
Authors: Lies Van Horebeek, An Goris, Bénédicte Dubois
- Neurocysticercosis: An Uncommon Cause of Acute Supratentorial Hydrocephalus(2022)
Authors: Bénédicte Dubois, Philippe Demaerel
- T1w/FLAIR ratio standardization as a myelin marker in MS patients(2022)
Authors: Sarah Cappelle, Stefan Sunaert, Annouschka Laenen, Bénédicte Dubois, Philippe Demaerel
- Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis(2021)
Authors: Maya Imbrechts, Stephanie Humblet-Baron, Bénédicte Dubois, Patrick Matthys, Adrian Liston, An Goris
- Genetic Variation in WNT9B Increases Relapse Hazard in Multiple Sclerosis(2021)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
Pages: 884 - 894